跳至主要内容
临床试验/NCT00698347
NCT00698347终止不适用

A Prospective, Non-controlled, Clinical Investigation of the M2a-Magnum™ Hip System

Biomet Orthopedics, LLC0 个研究点目标入组 249 人开始时间: 2004年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
249
主要终点
Harris Hip Score

研究概览

简要总结

The purpose of this prospective clinical data collection is to document the performance and clinical outcomes of the M2a-Magnum™ Hip System

详细描述

This is a 10 year prospective data collection documenting the function and survivorship of the M2a-Magnum™ Hip System. Patients are required to come in for preoperative, operative, one year follow-up, three year follow-up, five year follow-up, and ten year follow-up exams.

This product was FDA cleared in 2004.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Non-inflammatory degenerative joint disease including: Avascular Necrosis, Diastrophic Variant, Fracture of the Pelvis, Fused Hip, Leg Perthes, Osteoarthritis, Slipped Capital Epiphysis, Subcapital Fractures, Traumatic Arthritis
  • Rheumatoid Arthritis
  • Correction of Functional Deformity
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
  • Revision of previously failed total hip arthroplasty

排除标准

  • Absolute contraindications include:
  • Infection, Sepsis, and Osteomyelitis
  • Relative contraindications include:
  • Uncooperative patient or patient with neurologic disorders that are incapable of following directions
  • Osteoporosis
  • Metabolic disorders which may impair bone formation
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, or neuromuscular disease

结局指标

主要结局

Harris Hip Score

时间窗: 10 years

次要结局

  • Incidence of revisions, removals, and/or complications(Any time)
  • X-Rays(10 years)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验